Adenosine signaling has been implicated in cardiac adaptation to limited oxygen availability. In a wide search for adenosine receptor A2b (Adora2b)-elicited cardioadaptive responses, we identified the circadian rhythm protein period 2 (Per2) as an Adora2b target. Adora2b signaling led to Per2 stabilization during myocardial ischemia, and in this setting, Per2−/− mice had larger infarct sizes compared to wild-type mice and loss of the cardioprotection conferred by ischemic preconditioning. Metabolic studies uncovered a limited ability of ischemic hearts in Per2−/− mice to use carbohydrates for oxygen-efficient glycolysis. This impairment was caused by a failure to stabilize hypoxia-inducible factor-1α (Hif-1α). Moreover, stabilization of Per2 in the heart by exposing mice to intense light resulted in the transcriptional induction of glycolytic enzymes and Per2-dependent cardioprotection from ischemia. Together, these studies identify adenosine-elicited stabilization of Per2 in the control of HIF-dependent cardiac metabolism and ischemia tolerance and implicate Per2 stabilization as a potential new strategy for treating myocardial ischemia.
At a glance
- Hypoxia and inflammation. N. Engl. J. Med. 364, 656–665 (2011). &
- Physiological control of immune response and inflammatory tissue damage by hypoxia-inducible factors and adenosine A2A receptors. Annu. Rev. Immunol. 22, 657–682 (2004). et al.
- Ischemia and reperfusion—from mechanism to translation. Nat. Med. 17, 1391–1401 (2011). &
- The failing heart—an engine out of fuel. N. Engl. J. Med. 356, 1140–1151 (2007).
- Oxygen sensors at the crossroad of metabolism. Cell Metab. 9, 11–22 (2009). , , &
- Crucial role for ecto-5′-nucleotidase (CD73) in vascular leakage during hypoxia. J. Exp. Med. 200, 1395–1405 (2004). et al.
- Adenosine, an endogenous distress signal, modulates tissue damage and repair. Cell Death Differ. 14, 1315–1323 (2007).
- A2B adenosine receptor dampens hypoxia-induced vascular leak. Blood 111, 2024–2035 (2008). et al.
- Hypoxia-inducible factor-1 is central to cardioprotection: a new paradigm for ischemic preconditioning. Circulation 118, 166–175 (2008). , , , &
- Cardioprotection by ecto-5′-nucleotidase (CD73) and A2B adenosine receptors. Circulation 115, 1581–1590 (2007). et al.
- The mPer2 gene encodes a functional component of the mammalian circadian clock. Nature 400, 169–173 (1999). et al.
- Posttranslational mechanisms regulate the mammalian circadian clock. Cell 107, 855–867 (2001). , , , &
- Post-translational modifications regulate the ticking of the circadian clock. Nat. Rev. Mol. Cell Biol. 8, 139–148 (2007). &
- Neddylation and deneddylation regulate Cul1 and Cul3 protein accumulation. Nat. Cell Biol. 7, 1014–1020 (2005). , , &
- Antiinflammatory adaptation to hypoxia through adenosine-mediated cullin-1 deneddylation. J. Clin. Invest. 117, 703–711 (2007). , , &
- COPing with hypoxia. Semin. Cell Dev. Biol. 16, 462–473 (2005). &
- PER2 controls lipid metabolism by direct regulation of PPARγ. Cell Metab. 12, 509–520 (2010). et al.
- The cell biology of acute myocardial ischemia. Annu. Rev. Med. 42, 225–246 (1991). &
- Targeting fatty acid and carbohydrate oxidation—a novel therapeutic intervention in the ischemic and failing heart. Biochim. Biophys. Acta 1813, 1333–1350 (2011). , , , &
- Adenosine alters glucose use during ischemia and reperfusion in isolated rat hearts. Circulation 87, 900–908 (1993). , , &
- Glucose metabolism in the ischemic heart. Circulation 95, 313–315 (1997). &
- Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. J. Biol. Chem. 269, 23757–23763 (1994). , , &
- Mouse model for noninvasive imaging of HIF prolyl hydroxylase activity: assessment of an oral agent that stimulates erythropoietin production. Proc. Natl. Acad. Sci. USA 103, 105–110 (2006). et al.
- HIF-dependent induction of adenosine A2B receptor in hypoxia. FASEB J. 20, 2242–2250 (2006). , , , &
- Coordination of circadian timing in mammals. Nature 418, 935–941 (2002). &
- Photoperiodic regulation of PER1 and PER2 protein expression in rat peripheral tissues. Physiol. Res. 55, 623–632 (2006). &
- Metabolic approaches to the treatment of ischemic heart disease: the clinicians' perspective. Heart Fail. Rev. 7, 187–203 (2002). , , &
- The G(s)-coupled adenosine A(2B) receptor recruits divergent pathways to regulate ERK1/2 and p38. Exp. Cell Res. 290, 168–176 (2003). &
- Clock gene modulation by TNF-α depends on calcium and p38 MAP kinase signaling. J. Biol. Rhythms 24, 283–294 (2009). , , , &
- cAMP-dependent signaling as a core component of the mammalian circadian pacemaker. Science 320, 949–953 (2008). , , , &
- Regulation of CREB phosphorylation in the suprachiasmatic nucleus by light and a circadian clock. Science 260, 238–241 (1993). et al.
- The mammalian circadian timing system: organization and coordination of central and peripheral clocks. Annu. Rev. Physiol. 72, 517–549 (2010). , &
- Expression of circadian clock and melatonin receptors within cultured rat cardiomyocytes. Chronobiol. Int. 28, 21–30 (2011). et al.
- Constant darkness is a circadian metabolic signal in mammals. Nature 439, 340–343 (2006). , , &
- A role of erythrocytes in adenosine monophosphate initiation of hypometabolism in mammals. J. Biol. Chem. 285, 20716–20723 (2010). et al.
- Circadian variation in the frequency of onset of acute myocardial infarction. N. Engl. J. Med. 313, 1315–1322 (1985). et al.
- Circadian variations of infarct size in acute myocardial infarction. Heart 97, 970–976 (2011). et al.
- Circadian dependence of infarct size and left ventricular function after ST elevation myocardial infarction. Circ. Res. 110, 105–110 (2012). , , , &
- Clock genes display rhythmic expression in human hearts. Chronobiol. Int. 26, 621–636 (2009). et al.
- The human circadian clock entrains to sun time. Curr. Biol. 17, R44–R45 (2007). , &
- Responses of GLUT4-deficient hearts to ischemia underscore the importance of glycolysis. Circulation 103, 2961–2966 (2001). &
- AMP-activated protein kinase mediates ischemic glucose uptake and prevents postischemic cardiac dysfunction, apoptosis, and injury. J. Clin. Invest. 114, 495–503 (2004). et al.
- Hearts of hypoxia-inducible factor prolyl 4-hydroxylase-2 hypomorphic mice show protection against acute ischemia-reperfusion injury. J. Biol. Chem. 285, 13646–13657 (2010). et al.
- Hypoxia, HIF1 and glucose metabolism in the solid tumour. Nat. Rev. Cancer 8, 705–713 (2008).
- The cardiomyocyte circadian clock: emerging roles in health and disease. Circ. Res. 106, 647–658 (2010). &
- Metabolism and the control of circadian rhythms. Annu. Rev. Biochem. 71, 307–331 (2002). , &
- Invited review: regulation of mammalian circadian clock genes. J. Appl. Physiol. 92, 1348–1355 (2002).
- Short communication: ischemia/reperfusion tolerance is time-of-day-dependent: mediation by the cardiomyocyte circadian clock. Circ. Res. 106, 546–550 (2010). et al.
- A chronic mouse model of myocardial ischemia-reperfusion: essential in cytokine studies. Am. J. Physiol. Heart Circ. Physiol. 278, H1049–H1055 (2000). et al.
- Attenuation of myocardial injury in mice with functional deletion of the circadian rhythm gene mPer2. Am. J. Physiol. Heart Circ. Physiol. 298, H1088–H1095 (2010). et al.
- Increased vascular senescence and impaired endothelial progenitor cell function mediated by mutation of circadian gene Per2. Circulation 118, 2166–2173 (2008). et al.
- Mutation of the circadian clock gene Per2 alters vascular endothelial function. Circulation 115, 2188–2195 (2007). et al.
- Nonredundant roles of the mPer1 and mPer2 genes in the mammalian circadian clock. Cell 105, 683–694 (2001). et al.
- Hypoxia-inducible factor-1α is a positive factor in solid tumor growth. Cancer Res. 60, 4010–4015 (2000). et al.
- Temporally regulated and tissue-specific gene manipulations in the adult and embryonic heart using a tamoxifen-inducible Cre protein. Circ. Res. 89, 20–25 (2001). et al.
- PERIOD2:LUCIFERASE real-time reporting of circadian dynamics reveals persistent circadian oscillations in mouse peripheral tissues. Proc. Natl. Acad. Sci. USA 101, 5339–5346 (2004). et al.
- Systematic evaluation of a novel model for cardiac ischemic preconditioning in mice. Am. J. Physiol. Heart Circ. Physiol. 291, H2533–H2540 (2006). et al.
- Coordinated adenine nucleotide phosphohydrolysis and nucleoside signaling in posthypoxic endothelium: role of ectonucleotidases and adenosine A2B receptors. J. Exp. Med. 198, 783–796 (2003). et al.
- Method for isolation of adult mouse cardiac myocytes for studies of contraction and microfluorimetry. Am. J. Physiol. 271, H1250–H1255 (1996). &
- Stage-specific changes in myofilament protein phosphorylation following myocardial infarction in mice. J. Mol. Cell. Cardiol. 48, 1180–1186 (2010). , , &
- Supplementary Text and Figures (4M)
Supplementary Figures 1–19, Supplementary Tables 1–7 and Supplementary Methods